Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Therapeutic area

Vascular disorders – page 39

  • 846 clinical trials
  • 351 recruiting
  • 382 conditions
  • 28 countries

Conditions in this area

382 conditions with trials, the busiest first

Ischaemic stroke52Migraine48Pulmonary arterial hypertension41Systemic scleroderma40Coronary artery disease37Arteriosclerosis32Acute myocardial infarction30Hypertension29Pulmonary hypertension24Acute coronary syndrome21Giant cell arteritis18Paroxysmal nocturnal haemoglobinuria17Peripheral arterial occlusive disease17Septic shock17Cardiovascular disorder16Subarachnoid haemorrhage16Acute respiratory distress syndrome15Atrial fibrillation15Anti-neutrophil cytoplasmic antibody positive vasculitis14Cerebrovascular accident14Pulmonary embolism14Embolism13Myocardial infarction13Diabetic foot12+358

Clinical trials in Vascular disorders

846 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

846 clinical trials

Acute respiratory distress syndrome

Not yet recruiting

Study on Premedication with Ketamine or Fentanyl for Patients with Respiratory Distress Syndrome Receiving Surfactant Treatment

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:0–17 years
  • Substances:Fentanyl Citrate
  • Sponsor:Pohjois-Pohjanmaan hyvinvointialue

Coronary artery occlusion+1

Not yet recruiting

Study on Theophylline, Gadoteric Acid, and Regadenoson for Patients with Chronic Total Coronary Artery Blockage

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Gadoteric Acid
  • Sponsor:Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer

Acute respiratory distress syndrome

Not yet recruiting

Study on Pirfenidone for Preventing Lung Fibrosis in Patients with Acute Respiratory Distress Syndrome (ARDS)

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Pirfenidone
  • Sponsor:Ospedale San Raffaele S.r.l.

Ischaemic stroke

Not yet recruiting

Study on the Effects of CD34+ Cells for Patients with Acute Ischemic Stroke

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:AUTOLOGOUS CD34+ ENRICHED CELL FRACTION THAT CONTAINS CD34+ CELLS TRANSDUCED WITH RETROVIRAL VECTOR THAT ENCODES FOR THE HUMAN ADA CDNA SEQUENCE
  • Sponsor:Unidade Local De Saude De Coimbra E.P.E.

Diabetic foot

Not yet recruiting

Study on the Safety and Effects of Udonitrectag for Treating Diabetic Foot Ulcers in Patients

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Udonitrectag
  • Sponsor:Mimetech S.r.l.

Hypertension

Not yet recruiting

Study Comparing Eplerenone and Irbesartan for Lowering Blood Pressure in Obese Patients with Hypertension

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years
  • Substances:Amlodipine
  • Sponsor:Institute For Study Research Education And Therapy Of Vascular Heart Brain And Kidney Nosologies

Study on the Effect of Tranexamic Acid to Reduce Bleeding in Patients on Blood Thinners After Pacemaker Surgery

Not yet recruiting
Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Tranexamic Acid
  • Sponsor:Hospital Universitario Tajo

Peripheral arterial occlusive disease

Not yet recruiting

Study on Bone Marrow Cells and Saline for Treating Severe Limb Ischemia in Patients at High Risk of Amputation

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Saline
  • Sponsor:Fundacion Para La Investigacion Y La Innovacion Biosanitaria Del Principado De Asturias

Pulmonary embolism

Not yet recruiting

Study on Lung Function After Pulmonary Embolism Using Galligas and 68Ga-MAA in Patients with Pulmonary Embolism

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Graphite
  • Sponsor:Centre Hospitalier Regional Et Universitaire De Brest

Ischaemic stroke

Not yet recruiting

Study of dabigatran, apixaban and edoxaban for prevention of stroke recurrence in patients with acute ischemic stroke without known atrial fibrillation

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Universitaetsspital Basel

Congenital arterial malformation

Not yet recruiting

Study on Sirolimus and Prednisolone for Treating Superficial Arteriovenous Malformations in Patients

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Sirolimus
  • Sponsor:Centre Hospitalier Universitaire Amiens Picardie

Myocardial ischaemia

Not yet recruiting

Study on [68Ga]NODAGA-E[c(RGDyK)]2 for Imaging Blood Vessel Growth in Patients with Chronic Ischemic Heart Disease

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:[68GA]NODAGA-GLU(CYCLO[-ARG-GLY-ASP-D-TYR-LYS)]2
  • Sponsor:Rigshospitalet

Substances studied in this area

The therapies tested most often in Vascular disorders trials.

Acetylsalicylic Acid59 clinical trialsSodium Chloride55 clinical trialsClopidogrel33 clinical trialsApixaban28 clinical trialsTicagrelor28 clinical trialsRivaroxaban21 clinical trialsAtorvastatin17 clinical trialsPrasugrel17 clinical trialsRituximab16 clinical trials
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.